Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : YMI: YM Biosciences, Inc. (YMI on AMEX) -- Ignore unavailable to you. Want to Upgrade?

To: LaFayette555 who wrote (24)	2/11/2007 5:03:13 PM
From: DewDiligence_on_SI	Read Replies (1) \| Respond to of 66

…it's a stretch to state the FDA will allow trials in humans that ' never had a serious chance to succeed ' is this not obvious to you?? Not at all a stretch. If a company like YMI wants to test a crappy drug candidate like Tesmilifene and the trial design is reasonable, it’s not the FDA’s job to stop them. Buy low sell high is the name of the game, I say again this is the time to buy. It might be, but your statement at the start of this thread went well beyond that to asserting that YMI is a fine company. It isn’t. Sorry you lost your shirt here but you have to remain objective if you hope to make it. LOL—I’m on record for predicting last summer that the Tesmilifene trial would fail: investorshub.com There were surely ample red flags: investorshub.com Good luck.